MOSAIC IMMUNOENGINEERING, INC.: 10-Q filed 2014-01-14
What MOSAIC IMMUNOENGINEERING, INC. reported in its quarterly report filed 2014-01-14 (fiscal Q2 2014): 27 published measures, 68 facts as tagged in accession 0001019687-14-000167.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-01-14
- Fiscal period
- fiscal Q2 2014
- Accession
- 0001019687-14-000167 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MOSAIC IMMUNOENGINEERING, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 7,855,683 | USD | |
| At 2013-05-31 | 8,414,907 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 115,739 | USD | |
| At 2013-05-31 | 277,734 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 7,739,944 | USD | |
| At 2013-05-31 | 8,137,173 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 6,354,303 | USD | |
| At 2013-05-31 | 7,572,887 | USD | |
| At 2012-11-30 | 3,044,013 | USD | |
| At 2012-05-31 | 4,699,174 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2013-11-30 | 67,252 | USD | 91 |
| 2013-06-01 to 2013-11-30 | -419,638 | USD | 183 |
| 2012-09-01 to 2012-11-30 | 1,192,695 | USD | 91 |
| 2012-06-01 to 2012-11-30 | 300,283 | USD | 183 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-06-01 to 2013-11-30 | -847,120 | USD | 183 |
| 2012-06-01 to 2012-11-30 | -418,845 | USD | 183 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-06-01 to 2013-11-30 | 0 | USD | 183 |
| 2012-06-01 to 2012-11-30 | 1,240 | USD | 183 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-06-01 to 2013-11-30 | -40,009 | USD | 183 |
| 2012-06-01 to 2012-11-30 | -47,060 | USD | 183 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-06-01 to 2013-11-30 | -331,455 | USD | 183 |
| 2012-06-01 to 2012-11-30 | -1,189,256 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | -55,220,887 | USD | |
| At 2013-05-31 | -54,801,249 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2013-11-30 | 402,025,727 | shares | 91 |
| 2013-06-01 to 2013-11-30 | 402,215,280 | shares | 183 |
| 2012-09-01 to 2012-11-30 | 402,533,531 | shares | 91 |
| 2012-06-01 to 2012-11-30 | 402,665,735 | shares | 183 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2013-11-30 | 31,813 | USD | 91 |
| 2013-06-01 to 2013-11-30 | 35,713 | USD | 183 |
| 2012-09-01 to 2012-11-30 | 148 | USD | 91 |
| 2012-06-01 to 2012-11-30 | 2,713 | USD | 183 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 3,926 | USD | |
| At 2013-05-31 | 5,078 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-06-01 to 2013-11-30 | 62,418 | USD | 183 |
| 2012-06-01 to 2012-11-30 | 0 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 7,470,599 | USD | |
| At 2013-05-31 | 8,040,489 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 115,739 | USD | |
| At 2013-05-31 | 277,734 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 28,294 | USD | |
| At 2013-05-31 | 219,213 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-06-01 to 2013-11-30 | 40,009 | USD | 183 |
| 2012-06-01 to 2012-11-30 | 47,060 | USD | 183 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2013-11-30 | 373,491 | USD | 91 |
| 2013-06-01 to 2013-11-30 | 812,145 | USD | 183 |
| 2012-09-01 to 2012-11-30 | 238,171 | USD | 91 |
| 2012-06-01 to 2012-11-30 | 630,233 | USD | 183 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2013-11-30 | 373,491 | USD | 91 |
| 2013-06-01 to 2013-11-30 | 812,145 | USD | 183 |
| 2012-09-01 to 2012-11-30 | 238,171 | USD | 91 |
| 2012-06-01 to 2012-11-30 | 630,233 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 404,798,797 | shares | |
| At 2013-05-31 | 405,247,405 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 77,400,852 | USD | |
| At 2013-05-31 | 77,338,434 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 3,036 | USD | |
| At 2013-05-31 | 3,036 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-11-30 | 55,632 | USD | |
| At 2013-05-31 | 58,521 | USD |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-06-01 to 2013-11-30 | 1,152 | USD | 183 |
| 2012-06-01 to 2012-11-30 | 1,303 | USD | 183 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2013-11-30 | 472,331 | USD | 91 |
| 2013-06-01 to 2013-11-30 | 387,637 | USD | 183 |
| 2012-09-01 to 2012-11-30 | 1,429,936 | USD | 91 |
| 2012-06-01 to 2012-11-30 | 933,006 | USD | 183 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-06-01 to 2013-11-30 | 3,900 | USD | 183 |
| 2012-06-01 to 2012-11-30 | 0 | USD | 183 |
Inspect the source
- Entity
- MOSAIC IMMUNOENGINEERING, INC. / CIK 0000836564
- Captured
- 2026-09-19T15:08:56.564Z
- SEC response SHA-256
20b7dbddee8b1aee5cb56cb4cf5c3c14c36ef1fafb538ec0211cfb2585ddf3fd
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000836564.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))